LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on November 5, 2026

Nov. 5, 2026

Pyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO)

Indeterminate GlobeNewswire

Nov. 5, 2026

Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise

Indeterminate GlobeNewswire

Nov. 5, 2026

Tecnoglass Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Fate Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

OKYO Pharma to Present at the Stifel 2026 Healthcare Conference

Indeterminate GlobeNewswire

Nov. 5, 2026

Brookfield Business Corporation Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Bullish releases October 2026 monthly metrics

Indeterminate GlobeNewswire

Nov. 5, 2026

Agios Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Goliath Reports 14.61 g/t AuEq Over 6.00 Meters And 11.88 g/t AuEq Over 4 Meters Within Surebet Zone’s High-Grade Core Further Demonstrating Its Continuity And Predictability, Golddigger Property, Golden Triangle, B.C.

Indeterminate GlobeNewswire

Nov. 5, 2026

Rakovina Therapeutics to Present Brain-Penetrant ATR Inhibitor Data at the 31st Society for Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire

Nov. 5, 2026

Resalis Therapeutics Announces First-in-Human Data for RES-010 Demonstrating Safety and Tolerability with Early Weight Loss Signals

Indeterminate GlobeNewswire

Nov. 5, 2026

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

Indeterminate GlobeNewswire

Nov. 5, 2026

Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms

Indeterminate GlobeNewswire

Nov. 5, 2026

Notice of Q3 2026 Results and Webcast Details

Indeterminate GlobeNewswire

Nov. 5, 2026

EZVIZ Launches November Deals in Mexico: Up to 15% Off Smart Locks and 4K Security Cameras

Indeterminate GlobeNewswire

Nov. 5, 2026

Fortuna Reports Results for the Third Quarter 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar

Indeterminate GlobeNewswire

Nov. 5, 2026

HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia

Indeterminate GlobeNewswire